Consolidated Statements of Cash Flows (Unaudited) (USD $) In Thousands, unless otherwise specified	9 Months Ended
	Jan. 27, 2013		Jan. 25, 2012
Cash Flows from Operating Activities:
Net income	$ 829,080		$ 762,334
Adjustments to reconcile net income to cash provided by operating activities:
Depreciation	221,519		217,620
Amortization	34,890		33,965
Deferred tax benefit	(59,718)		(71,533)
Net loss on divestitures	19,765		0
Impairment on assets held for sale	36,000		0
Pension contributions	(53,251)		(15,490)
Other items, net	22,654		87,859
Changes in current assets and liabilities, excluding effects of acquisitions and divestitures:
Receivables (includes proceeds from securitization)	(148,132)		46,128
Inventories	(158,456)		(126,627)
Prepaid expenses and other current assets	5,699		(13,705)
Accounts payable	(42,852)		(182,333)
Accrued liabilities	(5,406)		(76,976)
Income taxes	(24,871)		82,272
Cash provided by operating activities	676,921		743,514
Cash Flows from Investing Activities:
Capital expenditures	(259,187)		(274,498)
Proceeds from disposals of property, plant and equipment	17,335		6,926
Proceeds from divestitures	16,783		664
Aquisitions, net of cash acquired	0		(3,250)
Sale of short-term investments	0		47,976
Change in restricted cash	3,994		(39,052)
Other items, net	(10,276)		(9,396)
Cash used for investing activities	(231,351)		(270,630)
Cash Flows from Financing Activities:
Payments on long-term debt	(216,972)		(831,553)
Proceeds from long-term debt	202,332		1,310,903
Net proceeds/(payments) on commercial paper and short-term debt	31,068		(56,943)
Dividends	(499,678)		(464,901)
Exercise of stock options	96,111		74,518
Purchase of treasury stock	(139,069)		(201,904)
Acquisitions of subsidiary shares from noncontrolling interest	(80,132)		(54,824)
Earn-out settlement	(44,547)		0
Other items, net	1,602		5,479
Cash used for financing activities	(649,285)		(219,225)
Effect of exchange rate changes on cash and cash equivalents	(26,037)		(129,059)
Net (decrease)/increase in cash and cash equivalents	(229,752)		124,600
Cash and cash equivalents at beginning of year	1,330,441	[1]	724,311
Cash and cash equivalents at end of period	$ 1,100,689		$ 848,911

[1] The year-end condensed consolidated balance sheet data was derived from audited financial statements, but does not include all disclosures required by accounting principles generally accepted in the United States of America.